Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0002 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 11/20/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One Bridge Plaza

Fort Lee, NJ 07024

United States

Phone: 201-592-6451

Fax: 201-592-0366

Neurologix, Inc., a development stage company, engages in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other therapies. The company’s development activities are focused on gene transfer for treating Parkinson’s disease. Its technology, referred to as ‘NLX,’ is in the clinical development stages, was tested in a Phase 1 and Phase 2 clinical trials to treat Parkinson’s disease. The company intends to continue to develop therapies to treat other neurodegenerative and metabolic disorders, including clinical testing for its therapy relating to Huntington’s disease. Agreements The company has a license agreement with Aegera Therapeutics Inc. whereby it was granted a license for the worldwide rights, excluding China, for the use of dXIAP for therapeutic or prophylactic purposes in the treatment of Huntington’s disease. In 2009, the company entered into a license agreement with Cornell University (Cornell), whereby Cornell granted it a license for the worldwide use of certain patents for the development of products and methods for the treatment of psychiatric conditions. History Neurologix, Inc. was founded in 1999.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NRGXQ:US $0.00 USD 0.00

NRGXQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NRGXQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation NRGXQ Industry Range
No financial data is available for NRGXQ.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEUROLOGIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at